1-20 of 3525
Journal Article
ACCEPTED MANUSCRIPT
Readmission Following Respiratory Syncytial Virus Hospitalization among Children < 5 Years of Age Get access
Journal of the Pediatric Infectious Diseases Society, piaf036, https://doi.org/10.1093/jpids/piaf036
Published: 29 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Risk of Highly Pathogenic Avian Influenza A/H5N1 Virus in Pediatrics Get access
Journal of the Pediatric Infectious Diseases Society, piaf035, https://doi.org/10.1093/jpids/piaf035
Published: 28 April 2025
Journal Article
Scientific Integrity Under Threat: The Role of the IDSA, PIDS, and SHEA Journals in an Evolving Political Landscape
Journal of the Pediatric Infectious Diseases Society, Volume 14, Issue 4, April 2025, piaf039, https://doi.org/10.1093/jpids/piaf039
Published: 28 April 2025
Image
Timelines of human and murine cerebellar and cochlear development. In human... Get access
Published: 25 April 2025
Figure 1.
Timelines of human and murine cerebellar and cochlear development. In humans, cerebellar development begins at approximately 24 gestational weeks (open horizontal bar). After birth, cerebellar maturation continues into childhood (open circle). In contrast, the mouse cerebellum develops after birth (
Journal Article
Effects of Cytomegalovirus-Induced Neuroinflammation on Central Nervous System Development Get access
Journal of the Pediatric Infectious Diseases Society, Volume 14, Issue 4, April 2025, piaf021, https://doi.org/10.1093/jpids/piaf021
Published: 25 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Pharmacokinetics and Safety of Ceftazidime-Avibactam in Neonates and Young Infants: a Phase 2a, Multicenter Prospective Trial
Journal of the Pediatric Infectious Diseases Society, piaf028, https://doi.org/10.1093/jpids/piaf028
Published: 19 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Patient Demographics are Associated with Testing for Group A Streptococcal Pharyngitis in Children
Journal of the Pediatric Infectious Diseases Society, piaf029, https://doi.org/10.1093/jpids/piaf029
Published: 14 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Billing for and documentation of provider-to-provider interprofessional consults in infectious diseases Get access
Journal of the Pediatric Infectious Diseases Society, piaf033, https://doi.org/10.1093/jpids/piaf033
Published: 14 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Pediatric COVID-19 in Hawaiʻi: A Brief Report on Unique Hospitalization Characteristics Get access
Journal of the Pediatric Infectious Diseases Society, piaf030, https://doi.org/10.1093/jpids/piaf030
Published: 10 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Survey response rates: Reassessing expectations Get access
Journal of the Pediatric Infectious Diseases Society, piaf031, https://doi.org/10.1093/jpids/piaf031
Published: 09 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Pharmacokinetics and Safety of Single-dose Sotrovimab in High-risk Children and Adolescents with Mild-to-moderate COVID-19
Journal of the Pediatric Infectious Diseases Society, piaf027, https://doi.org/10.1093/jpids/piaf027
Published: 27 March 2025
Image
A) BAL Pathogen Yield Based on Underlying Conditions. Abbreviations: CNS—Ce...
Published: 24 March 2025
Figure 1.
A) BAL Pathogen Yield Based on Underlying Conditions. Abbreviations: CNS—Central Nervous System, HCT—Hematopoietic Cell Transplantation. *Statistically Significantly Higher Yield ( P .005) Compared to Other Groups. B) BAL Yield Based on Days Since Antimicrobial Initiation. The Vertical Dotted Line
Image
A) BAL Pathogen Yield Based on Underlying Conditions. Abbreviations: CNS—Ce...
Published: 24 March 2025
Figure 1.
A) BAL Pathogen Yield Based on Underlying Conditions. Abbreviations: CNS—Central Nervous System, HCT—Hematopoietic Cell Transplantation. *Statistically Significantly Higher Yield ( P .005) Compared to Other Groups. B) BAL Yield Based on Days Since Antimicrobial Initiation. The Vertical Dotted Line
Journal Article
Utility of Bronchoalveolar Lavage in Immunocompromised Children: Is the Bronch Result in the Eye of the Beholder or Is It a Wash? Get access
Journal of the Pediatric Infectious Diseases Society, Volume 14, Issue 3, March 2025, piaf018, https://doi.org/10.1093/jpids/piaf018
Published: 24 March 2025
Journal Article
Utility and Safety of Bronchoalveolar Lavage for Diagnosis and Management of Respiratory Illnesses in Immunocompromised Children
Journal of the Pediatric Infectious Diseases Society, Volume 14, Issue 3, March 2025, piaf015, https://doi.org/10.1093/jpids/piaf015
Published: 24 March 2025
Image
Source of Pathogen Yield and Agreement With ARI diagnosis. “Pathogen Yield”...
Published: 24 March 2025
Figure 2.
Source of Pathogen Yield and Agreement With ARI diagnosis. “Pathogen Yield” Refers to Detection of Any Microbe (Viral, Bacterial, And Fungal) Which May or May Not Have Been the Etiological Cause of the ARI. “Diagnosis Agreement” Refers to Concordance of the Yield (Includes Positive And Negative) Fro
Journal Article
The Epidemiology and Burden of Human Parainfluenza Virus Hospitalizations in US Children Get access
Journal of the Pediatric Infectious Diseases Society, Volume 14, Issue 4, April 2025, piaf026, https://doi.org/10.1093/jpids/piaf026
Published: 22 March 2025
Image
Flow chart of children < 18 years hospitalized with parainfluenza virus ... Get access
Published: 22 March 2025
Figure 1.
Flow chart of children < 18 years hospitalized with parainfluenza virus (PIV)-associated acute respiratory infection (ARI), December 2016–March 2020, New Vaccine Surveillance Network.
Image
Seasonal distribution of parainfluenza virus (PIV)-associated acute respira... Get access
Published: 22 March 2025
Figure 3.
Seasonal distribution of parainfluenza virus (PIV)-associated acute respiratory infection (ARI) hospitalizations by PIV type, for children < 18 years hospitalized December 2016–March 2020, New Vaccine Surveillance Network.
Image
Rates of parainfluenza virus (PIV)-associated acute respiratory infection (... Get access
Published: 22 March 2025
Figure 2.
Rates of parainfluenza virus (PIV)-associated acute respiratory infection (ARI) hospitalizations per 1,000 children per year (95% CI) by PIV type and age group, for children < 18 years hospitalized December 2016–March 2020, New Vaccine Surveillance Network.
